-
PanCuRx Translational Research Initiative
Study
EGAS00001002543
-
Pharmacogenomic Analysis Reveals New Therapeutic Options for Pleural Mesothelioma
Study
EGAS00001007866
-
Exome sequencing data from two myelosarcomas
Study
EGAS00001002562
-
Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks
Study
EGAS00001002571
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__pancreas
Study
EGAS00001002726
-
Novel paediatric case of a spinal high-grade astrocytoma with piloid features in a patient with Noonan Syndrome
Study
EGAS00001007937
-
Comprehensive genetic analysis of uveal melanoma heterogeneity during metastatic progression
Study
EGAS00001002761
-
A genomic approach towards an understanding of clonal evolution and disease progression in multiple myeloma
Study
EGAS00001002850
-
Integrative multi-omic analyses of malignant pleural mesothelioma
Study
EGAS00001004812
-
EATL-II STUDY
Study
EGAS00001001879
-
The G2 gene expression signature and MYC overexpression are independent poor prognostic factors in childhood high-grade osteosarcoma
Study
EGAS00001008073
-
Angiosarcoma_targeted_pulldown_cancer_gene_panel
Study
EGAS00001000589
-
Integrated Molecular Profilting in Advanced Cancers Trial
Study
EGAS00001001897
-
Comparison of EGF and PDGF driven glioblastomas.
Study
EGAS00001001900
-
Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma
Study
EGAS00001008140
-
High-Resolution Spatial Transcriptomics Uncover Epidermal-Dermal Divergences in Merkel Cell Carcinoma: Spatial Context Reshapes the Gene Expression Landscape
Study
EGAS00001008157
-
WTCCC2 project Glaucoma (GL) samples
Study
EGAS00001000624
-
Influence of age on molecular changes and treatment stratification in multimodal glioblastoma therapy
Study
EGAS00001008246
-
RNA sequencing of chondrosarcoma
Study
EGAS00001004585
-
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
Study
EGAS00001001916
-
Feasibility Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN) in resectable stage III melanoma patients
Study
EGAS00001003099
-
BLUEPRINT Bisulfite-seq and Whole Genome Sequencing of mantle cell lymphoma
Study
EGAS00001001638
-
Genomic characterization of NUT midline carcinoma
Study
EGAS00001001934
-
Exome sequence data for germline, primary tumor, and relapse tumor of a transformed non-Hodgkins lymphoma patient with unexpected long-time remission
Study
EGAS00001001973
-
Whole genome sequencing of Ewings Sarcoma
Study
EGAS00001003385